Voyager Therapeutics: Q3 Earnings Snapshot

LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Thursday reported a loss of $24.7 million in its third quarter.

The Lexington, Massachusetts-based company said it had a loss of 40 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 41 cents per share.

The gene therapy company posted revenue of $4 million in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $4.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR